New study challenges assumptions about the development of RA
Scientists have discovered that each rheumatoid arthritis patient possesses a unique and diverse set of ACPAs.
List view / Grid view
Scientists have discovered that each rheumatoid arthritis patient possesses a unique and diverse set of ACPAs.
Induced NPCs facilitate the creation of patient-specific organoid models and improve identification of nephron targeted drugs.
Researchers discovered that measuring the concentrations of IL-18 in an individual’s blood could estimate future risk of stroke.
Confounder control and quantitative profiling revealed misleading associations between microbial markers and colorectal cancer development.
Researchers discovered that smooth muscle cells can change into cancer-like cell types and worsen atherosclerosis.
Researchers have revealed that genetically enhanced expression of GSDMB causes a disturbed interferon-response.
A synthetic antibody selectively activates the Wnt signalling pathway and directs stem cells to differentiate into neurons.
The study’s findings explain the genetic differences in people’s blood pressure, which could lead to personalised medicine approaches.
The mouse model provides a new understanding of the fundamental aspects of KSHV, which will enable drug and vaccine development.
The new organoids demonstrate a greater diversity of TECs in culture and are capable of maturing T cells.
Adult anxious behaviour in offspring may be related to the early life proinflammatory state caused by the absence of elevated XCL1.
Injections of cardiac spheroids into primate ventricles improved left ventricular ejection after four weeks.
In animal studies, the new vaccine construct outperformed another PNAG-vaccine delivery system currently in human trials.
Scientists found that preventing the effects of prostaglandin E2 could be an effective therapy to overcome tumour defence.
The mini-colons are topobiologically complex, can be induced to develop tumours in targeted areas and reduce the use of animal models.